Clinical Trial Finder Search Results

About the Fight CRC Clinical Trial Finder

This Trial Finder is a one-stop place to find and learn more about high-impact clinical trials for colorectal cancer patients with advanced colon or rectal cancer. Originally created by the late Dr. Tom Marsilje as a curated spreadsheet of trials, the FightCRC’s Trial Finder is a resource to find research studies that are open in your geography, and for which you may be eligible. The current data is now for metastatic, stage IV patients with both MSS and MSI-H status. The list of trials here is sourced from the ClinicalTrials.gov website and curated with Comments and Helpful Links. The searches can be focused on immunotherapy-centered trials and narrowed to studies enrolling patients who already have received immunotherapies.

Medical Disclaimer

The information contained in this website is not intended to recommend the self management of health problems, medical conditions or wellness. It is not intended to endorse or recommend any particular type of medical treatment, physician or treatment facility. Should any reader have any health care related questions, promptly call or consult your physician or healthcare provider. The information contained in this website should NOT be used by any reader to disregard medical and/or health related advice or provide a basis to delay consultation with a physician or a qualified healthcare provider. Fight Colorectal Cancer disclaims any liability based on information provided in this website.

Ubicación

MS status

Recruitment Status

Fase

Drogas

Inmunoterapia previa permitida

NCT ID

Title key word search

Fecha en que se añadió el juicio

From To

View:

Compact Expanded

PDF Excel CSV

NCT ID	Title	Fase	Date Added	Ubicación	Prior IO Allowed	CRC-directed	Status	Drogas	Etiquetas
NCT ID NCT03577665	TitleTerapia curativa con haz de protones para pacientes con metástasis hepática de cáncer colorrectal	Fase No aplicable	Date Added 2018-07-05	Ubicación Corea, República de	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT04687631	TitleConversion Therapy of RAS/BRAF Wild-Type Colorectal Cancer Patients With Initially Unresectable Liver Metastases	Fase Fase 3	Date Added 2020-12-29	Ubicación China	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas mFOLFOXIRI Plus Bevacizumab, mFOLFOXIRI plus Cetuximab	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT05768503	TitleComparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC	Fase Fase 3	Date Added 2023-03-14	Ubicación China	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas Control Rx, Experimental drug	Etiquetas MSS/ MMRp
NCT ID NCT05990543	TitleCombination of Nelmastobart and Capecitabine Therapy in Metastatic Colorectal Cancer	Fase Fase 1	Date Added 2023-08-14	Ubicación	Prior IO Allowed Sí	CRC-directed Sí	Status Aún no se ha contratado	Drogas Nelmastobart and Capecitabine	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT02997228	TitleCombination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer, the COMMIT Study	Fase Fase 3	Date Added 2016-12-20	Ubicación Arizona, United States Arkansas, United States California, United States Colorado, United States Connecticut, United States Delaware, United States District of Columbia, United States Florida, United States Georgia, United States Idaho, United States Illinois, United States Indiana, United States Iowa, United States Kansas, United States Kentucky, United States Louisiana, United States Maine, United States Maryland, United States Massachusetts, United States Michigan, United States Minnesota, United States Mississippi, United States Missouri, United States Montana, United States Nebraska, United States Nevada, United States New Hampshire, United States New Jersey, United States New Mexico, United States New York, United States North Carolina, United States North Dakota, United States Ohio, United States Oklahoma, United States Oregon, United States Pennsylvania, United States South Carolina, United States South Dakota, United States Tennessee, United States Texas, United States Utah, United States Vermont, United States Virginia, United States Washington, United States West Virginia, United States Wisconsin, United States Wyoming, United States	Prior IO Allowed No	CRC-directed Sí	Status Suspendido	Drogas Atezolizumab, fluorouracil, Leucovorin, oxaliplatin	Etiquetas MSI-H/ MMRd
NCT ID NCT03088150	TitleEnsayo COLLISION - Metástasis hepáticas colorrectales: Cirugía frente a ablación térmica	Fase Fase 3	Date Added 2017-03-23	Ubicación Países Bajos	Prior IO Allowed Sí	CRC-directed Sí	Status Unknown status	Drogas	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT06185556	TitleCOLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascular and Peribiliary Colorectal Liver Metastases	Fase Fase 2	Date Added 2023-12-29	Ubicación Países Bajos	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT05999812	TitleClinical Trial of All-trans-retinoic Acid, Bevacizumab and Atezolizumab in Colorectal Cancer	Fase Fase 2	Date Added 2023-08-21	Ubicación Texas, United States	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas all trans Retinoic Acid, Atezolizumab, Bevacizumab	Etiquetas MSS/ MMRp
NCT ID NCT05676190	TitleClinical Study on the Efficacy of Autologous Cell Factor Induced Killer Cells in the Treatment of Colorectal Cancer	Fase No aplicable	Date Added 2023-01-09	Ubicación China	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT06026774	TitleClinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Subjects With Resected Digestive System Neoplasms	Fase Fase 1	Date Added 2023-09-07	Ubicación China	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas	Etiquetas MSI-H/ MMRd, MSS/ MMRp

Showing 191 to 200 of 299 entries